Association of serum apoA-I with in-stent restenosis in coronary heart disease

被引：0
|
作者：
Xin Wang
Min Zhang
Jie Cheng
Hua Zhou
机构：
[1] Tongji University,Department of Cardiology, School of Medicine, East Hospital
[2] Shanghai Jiao Tong University,Department of Cardiology, School of Medicine, Ren Ji Hospital
[3] Shanghai Jiao Tong University,Center for Reproductive Medicine, School of Medicine, Ren Ji Hospital
来源：
BMC Cardiovascular Disorders | / 22卷
关键词：
In-stent restenosis; apoA-I; Drug-eluting stents; Prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Brachytherapy of an in-stent stenosis in coronary heart disease
    Niewöhner-Desbordes, U
    Kowalski, M
    Franz, N
    Stahl, W
    Baumbach, T
    Wagner, W
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 82 - 82
  • [32] The Relationship Between Serum SFRP5, ApoA-I, HDL3-C Level and In-Stent Restenosis After PCI in Acute Myocardial Infarction and the Combined Predictive Value
    Cui, Li-Qiang
    Wang, Xue-Dong
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2025,
  • [33] Coronary In-Stent Restenosis: Assessment with CT Coronary Angiography
    Andreini, Daniele
    Pontone, Gianluca
    Mushtaq, Saima
    Bartorelli, Antonio L.
    Bertella, Erika
    Trabattoni, Daniela
    Montorsi, Piero
    Galli, Stefano
    Foti, Claudia
    Annoni, Andrea
    Bovis, Francesca
    Ballerini, Giovanni
    Agostoni, Piergiuseppe
    Fiorentini, Cesare
    Pepi, Mauro
    RADIOLOGY, 2012, 265 (02) : 410 - 417
  • [34] APOA-I containing lipoprotein particles, insulin and coronary heart disease in patients with syndrome X.
    Kylync, C
    Yyldyrymkaya, M
    Yylmaz, K
    Narin, Y
    Ozkan, MO
    Kutluay, T
    CLINICAL CHEMISTRY, 1997, 43 : 695 - 695
  • [35] Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: From Western Denmark heart registry
    Jensen, Jesper Khedri
    Jensen, Lisette Okkels
    Terkelsen, Christian Juhl
    Lassen, Jens Flensted
    Tilsted, Hans Henrik
    Hansen, Knud Noerregaard
    Maeng, Michael
    Thuesen, Leif
    Thayssen, Per
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (02) : 260 - 265
  • [36] Stent graft implantation for in-stent restenosis of coronary artery stenosis after Kawasaki disease
    Yoon, Min Jeong
    Lee, Jae Young
    Kim, Soo-Jin
    Jang, Ki Young
    Shim, Woo Sup
    Hwang, Hweung Kon
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 113 (02) : 264 - 266
  • [37] An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
    Demyanets, Svitlana
    Tentzeris, Ioannis
    Jarai, Rudolf
    Katsaros, Katharina M.
    Farhan, Serdar
    Wonnerth, Anna
    Weiss, Thomas W.
    Wojta, Johann
    Speidl, Walter S.
    Huber, Kurt
    CYTOKINE, 2014, 67 (02) : 65 - 70
  • [38] Rosiglitazone reduces in-stent restenosis in diabetic patients with coronary artery disease
    不详
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (09) : 675 - 675
  • [39] Delayed Coronary In-stent Restenosis and Disease Progression in Patients with Single Vessel Coronary Artery Disease
    Albertal, Mariano
    Seoane, Leonardo
    Nau, Gerardo
    Candiello, Alfonsina
    Padilla, Lucio T.
    Belardi, Jorge
    Cura, Fernando
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B147 - B147
  • [40] Treatment of coronary in-stent restenosis:a systematic review
    Leos Pleva
    Pavel Kukla
    Ota Hlinomaz
    Journal of Geriatric Cardiology, 2018, 15 (02) : 173 - 184
12345